These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19068689)

  • 1. [Case of androgenic anabolic steroid abuse caused hypogonadotropic hypogonadism].
    Takayanagi A; Kobayashi K; Hashimoto K; Kato R; Masumori N; Itoh N; Tsukamoto T
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):729-32. PubMed ID: 19068689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
    Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
    PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic steroid-induced hypogonadism: diagnosis and treatment.
    Rahnema CD; Lipshultz LI; Crosnoe LE; Kovac JR; Kim ED
    Fertil Steril; 2014 May; 101(5):1271-9. PubMed ID: 24636400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
    Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
    Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
    Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
    Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
    Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
    J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin.
    Gill GV
    Postgrad Med J; 1998 Jan; 74(867):45-6. PubMed ID: 9538490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
    Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
    Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men.
    Pope HG; Kanayama G
    Endocrinol Metab Clin North Am; 2022 Mar; 51(1):205-216. PubMed ID: 35216717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
    Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
    Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic steroid induced hypogonadism in young men.
    Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
    J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Central Effects of Androgenic-anabolic Steroid Use.
    Mędraś M; Brona A; Jóźków P
    J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Response to Gonadotropin-Releasing Hormone and hCG in Men with Prior Chronic Androgen Steroid Abuse and Clinical Hypogonadism.
    Flanagan JN; Lehtihet M
    Horm Metab Res; 2015 Aug; 47(9):668-73. PubMed ID: 25642745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use, Misuse and Abuse of Testosterone and Other Androgens.
    Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
    Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent primary hypogonadism associated with anabolic steroid abuse.
    Boregowda K; Joels L; Stephens JW; Price DE
    Fertil Steril; 2011 Jul; 96(1):e7-8. PubMed ID: 21575947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use, Misuse and Abuse of Testosterone and Other Androgens.
    Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
    Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 34887237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deleterious effects of anabolic androgenic steroid abuse on sexual and reproductive health and comparison of recovery between treated and untreated patients: Single-center prospective randomized study.
    Al Hashimi M
    Andrologia; 2022 Dec; 54(11):e14576. PubMed ID: 36065528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.
    Karavolos S; Reynolds M; Panagiotopoulou N; McEleny K; Scally M; Quinton R
    Clin Endocrinol (Oxf); 2015 May; 82(5):624-32. PubMed ID: 25333666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.